Refractory bipolar disorder and neuroprogression

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 70, Issue , 2016, Pages 103-110

  da Costa, Sabrina C ^a   Passos, Ives C ^a,b   Lowri, Caroline ^a   Soares, Jair C ^a   Kapczinski, Flavio ^a,b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Bipolar disorder; Neuroprogression; Sensitization cross sensitization; Therapeutic interventions; Treatment refractoriness

Indexed keywords

BIOLOGICAL MARKER; CARBAMAZEPINE; CLOZAPINE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; LITHIUM; SOLUBLE INTERLEUKIN 2 RECEPTOR; SOLUBLE INTERLEUKIN 6 RECEPTOR; SOLUBLE TUMOR NECROSIS FACTOR ALPHA RECEPTOR 1; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; TUMOR NECROSIS FACTOR ALPHA RECEPTOR 1; UNCLASSIFIED DRUG; VALPROIC ACID;

ARTICLE; AUTOPSY; BIPOLAR DISORDER; COGNITIVE BEHAVIORAL THERAPY; COGNITIVE DEFECT; COGNITIVE REMEDIATION THERAPY; CROSS ALLERGY; DEPRESSION; DISEASE COURSE; FAMILY THERAPY; FUNCTIONAL DISEASE; GROUP THERAPY; HUMAN; NEUROIMAGING; NEUROPROGRESSION; REFRACTORY BIPOLAR DISORDER; RISK FACTOR; SENSITIZATION; ANIMAL; DRUG RESISTANCE; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; BIPOLAR DISORDER; DISEASE PROGRESSION; DRUG RESISTANCE; HUMANS;

EID: 84942032748     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2015.09.005     Document Type: Article

References (124)

1. Adler, Caleb M., Adams, John, DelBello, Melissa P., Holland, Scott K., Schmithorst, Vince, Levine, Ari, Jarvis, Kelly, Strakowski, Stephen M., Evidence of white matter pathology in bipolar disorder adolescents experiencing their first episode of mania: A diffusion tensor imaging study. Am. J. Psychiatr. 163:2 (2006), 322–324, 10.1176/appi.ajp.163.2.322.
2. Anaya, Celia, Aran, Anabel Martinez, Jose, L., Ayuso-Mateos, Til Wykes, Vieta, Eduard, Scott, Jan, A systematic review of cognitive remediation for schizo-affective and affective disorders. J. Affect. Disord. 142:1–3 (2012), 13–21, 10.1016/j.jad.2012.04.020.
3. Andreazza, Ana Cristina, Frey, Benicio Noronha, Erdtmann, Bernardo, Salvador, Mirian, Rombaldi, Fernanda, Santin, Aida, Gonçalves, Carlos Alberto, Kapczinski, Flavio, DNA damage in bipolar disorder. Psychiatry Res. 153:1 (2007), 27–32, 10.1016/j.psychres.2006.03.025.
4. Bai, Ya-Mei, Tung-Ping, Su., Tsai, Shih-Jen, Wen-Fei, Chiou, Cheng-Ta Li, Tu., Pei-Chi, Tu, Mu-Hong, Chen, Comparison of inflammatory cytokine levels among type I/type II and manic/hypomanic/euthymic/depressive states of bipolar disorder. J. Affect. Disord. 166 (2014), 187–192, 10.1016/j.jad.2014.05.009.
5. (September 2014).
6. Barone, Veronica, Peralta, Juan E., Magnetic boron nitride nanoribbons with tunable electronic properties. Nano Lett. 8:8 (2008), 2210–2214, 10.1021/nl080745j.
7. Bauer, Isabelle E., Pascoe, Michaela C., Wollenhaupt-Aguiar, Bianca, Kapczinski, Flavio, Soares, Jair C., Inflammatory mediators of cognitive impairment in bipolar disorder. J. Psychiatr. Res., 2014, 10.1016/j.jpsychires.2014.04.017.
8. Belmaker, R.H., Agam, G., van Calker, D., Richards, M.H., Kofman, O., Behavioral reversal of lithium effects by four inositol isomers correlates perfectly with biochemical effects on the PI cycle: Depletion by chronic lithium of brain inositol is specific to hypothalamus, and inositol levels may be abnormal in postmortem Br. Neuropsychopharmacology 19:3 (1998), 220–232, 10.1016/S0893-133X(98)00017-7.
9. Berk, Michael, Conus, Philippe, Lucas, Nellie, Hallam, Karen, Gin, S., Malhi, Seetal Dodd, Lakshmi, N., Yatham, Alison Yung, McGorry, Pat, Setting the stage: From prodrome to treatment resistance in bipolar disorder. Bipolar Disord. 9:7 (2007), 671–678, 10.1111/j.1399-5618.2007.00484.x.
10. Berk, Michael, Hallam, Karen, Gin, S., Malhi, Lisa Henry, Hasty, Melissa, Macneil, Craig, Yucel, Murat, et al. Evidence and implications for early intervention in bipolar disorder. J. Ment. Health (Abingdon, England) 19:2 (2010), 113–126, 10.3109/09638230903469111.
11. Berk, M., Kapczinski, F., Andreazza, A.C., Dean, O.M., Giorlando, F., Maes, M., Yücel, M., et al. Pathways underlying neuroprogression in bipolar disorder: Focus on inflammation, oxidative stress and neurotrophic factors. Neurosci. Biobehav. Rev., 2011, 10.1016/j.neubiorev.2010.10.001.
12. Berk, Michael, Brnabic, Alan, Dodd, Seetal, Kelin, Katarina, Tohen, Mauricio, Gin, S., Malhi, Lesley Berk, Conus, Philippe, McGorry, Patrick D., Does stage of illness impact treatment response in bipolar disorder? empirical treatment data and their implication for the staging model and early intervention. Bipolar Disord. 13:1 (2011), 87–98, 10.1111/j.1399-5618.2011.00889.x.
13. Berk, Michael, Berk, Lesley, Dodd, Seetal, Cotton, Sue, Macneil, Craig, Daglas, Rothanthi, Conus, Philippe, Bechdolf, Andreas, Moylan, Steven, Malhi, Gin S., Stage managing bipolar disorder. Bipolar Disord., 2014, 10.1111/bdi.12099.
14. Blumberg, Hilary P., Krystal, John H., Bansal, Ravi, Martin, Andrés, Dziura, James, Durkin, Kathleen, Martin, Laura, Gerard, Elizabeth, Charney, Dennis S., Peterson, Bradley S., Age, rapid-cycling, and pharmacotherapy effects on ventral prefrontal cortex in bipolar disorder: A cross-sectional study. Biol. Psychiatry 59:7 (2006), 611–618, 10.1016/j.biopsych.2005.08.031.
15. Botteron, K.N., Figiel, G.S., Wetzel, M.W., Hudziak, J., VanEerdewegh, M., MRI abnormalities in adolescent bipolar affective disorder. J. Am. Acad. Child Adolesc. Psychiatry 31 (1992), 258–261.
16. Boyle, Lisa L., Anton, P., Porsteinsson, Xingjia Cui, King, Deborah A., Lyness, Jeffrey M., Depression predicts cognitive disorders in older primary care patients. J. Clin. Psychiatry 71:1 (2010), 74–79, 10.4088/JCP.08m04724gry.
17. Caspi, Avshalom, Sugden, Karen, Moffitt, Terrie E., Taylor, Alan, Craig, Ian W., Harrington, HonaLee, McClay, Joseph, et al. Influence of life stress on depression: Moderation by a polymorphism in the 5-HTT gene. Science (New York, N.Y.) 301:5631 (2003), 386–389, 10.1126/science.1083968.
18. Chen, Chi Hua, Suckling, John, Lennox, Belinda R., Ooi, Cinly, Bullmore, Ed T., A quantitative meta-analysis of fMRI studies in bipolar disorder. Bipolar Disord., 2011, 10.1111/j.1399-5618.2011.00893.x.
19. Colom, Francesc, Vieta, Eduard, A perspective on the use of psychoeducation, cognitive-behavioral therapy and interpersonal therapy for bipolar patients. Bipolar Disord. 6:6 (2004), 480–486, 10.1111/j.1399-5618.2004.00136.x.
20. Compton, Michael T., Gordon, Tynessa L., Goulding, Sandra M., Esterberg, Michelle L., Carter, Tandrea, Leiner, Amy S., Weiss, Paul S., Druss, Benjamin G., Walker, Elaine F., Kaslow, Nadine J., Patient-level predictors and clinical correlates of duration of untreated psychosis among hospitalized first-episode patients. J. Clin. Psychiatry, 2011, 10.4088/JCP.09m05704yel.
21. Crump, Casey, Sundquist, Kristina, Winkleby, Marilyn A., Sundquist, Jan, Comorbidities and mortality in bipolar disorder: A swedish national cohort study. JAMA Psychiatry 70:9 (2013), 931–939, 10.1001/jamapsychiatry.2013.1394.
22. Dotson, Vonetta M., Beydoun, May A., Zonderman, Alan B., Recurrent depressive symptoms and the incidence of dementia and mild cognitive impairment. Neurology 75:1 (2010), 27–34, 10.1212/WNL.0b013e3181e62124.
23. Fountoulakis, Konstantinos N., Refractoriness in bipolar disorder: Definitions and evidence-based treatment. CNS Neurosci. Ther. 18:3 (2012), 227–237, 10.1111/j.1755-5949.2011.00259.x.
24. Fountoulakis, Konstantinos N., Vieta, Eduard, Treatment of bipolar disorder: A systematic review of available data and clinical perspectives. Int. J. Neuropsychopharmacol. 11:7 (2008), 999–1029, 10.1017/S1461145708009231.
25. Frazier, Jean A., Breeze, Janis L., Papadimitriou, George, Kennedy, David N., Hodge, Steven M., Moore, Constance M., Howard, James D., Rohan, Michael P., Caviness, Verne S., Makris, Nikos, White matter abnormalities in children with and at risk for bipolar disorder. Bipolar Disord. 9:8 (2007), 799–809, 10.1111/j.1399-5618.2007.00482.x.
26. Frey, Benicio N., Giovana, B., Zunta-Soares, Sheila C., Caetano, Mark A., Nicoletti, John P., Hatch, Paolo Brambilla, Mallinger, Alan G., Soares, Jair C., Illness duration and total brain gray matter in bipolar disorder: Evidence for neurodegeneration?. Eur. Neuropsychopharmacol. 18:10 (2008), 717–722, 10.1016/j.euroneuro.2008.04.015.
27. Fries, Gabrielrodrigo, Paiva Vasconcelos-Moreno, Mirela, Gubert, Carolina, Tietböhl Martins Quadros Dos Santos, Barbara, Teixeira Da Rosa, André Luiz Schuh, Eisele, Bárbara, Sartori, Juliana, Pfaffenseller, Bianca, Kapczinski, Flávio, Kauer-Sant'Anna, Márcia, Early apoptosis in peripheral blood mononuclear cells from patients with bipolar disorder. J. Affect. Disord. 152–154:1 (2014), 474–477, 10.1016/j.jad.2013.07.027.
28. Gigante, Alexandre Duarte, Young, Lionel Trevor, Lakshmi, N., Yatham, Ana Cristina, Andreazza, Fabiano Gonçalves, Nery, Lea Tenenholz, Grinberg, Helmut Heinsen, Lafer, Beny, Morphometric post-mortem studies in bipolar disorder: Possible association with oxidative stress and apoptosis. Int. J. Neuropsychopharmacol. 14:8 (2011), 1075–1089, 10.1017/S146114571000146X.
29. Gildengers, Ariel G., Chung, Kuo-Hsuan, Huang, Shou-Hung, Begley, Amy, Aizenstein, Howard J., Tsai, Shang-Ying, Neuroprogressive effects of lifetime illness duration in older adults with bipolar disorder. Bipolar Disord. 16:6 (2014), 617–623, 10.1111/bdi.12204.
30. Gitlin, M.J., Treatment-resistant bipolar disorder. Bull. Menn. Clin. 65:1 (2001), 26–40.
31. Gitlin, M., Treatment-resistant bipolar disorder. Mol. Psychiatry 11:3 (2006), 227–240, 10.1038/sj.mp.4001793.
32. Gitlin, M.J., Swendsen, J., Heller, T.L., Hammen, C., Relapse and impairment in bipolar disorder. Am. J. Psychiatry 152:11 (1995), 1635–1640.
33. Goldberg, Joseph F., Ernst, Carrie L., Features associated with the delayed initiation of mood stabilizers at illness onset in bipolar disorder. J. Clin. Psychiatry 63:11 (2002), 985–991.
34. Goldberg, J.F., Harrow, M., Grossman, L.S., Course and outcome in bipolar affective disorder: A longitudinal follow-up study. Am. J. Psychiatry 152:3 (1995), 379–384.
35. Goldberg, J.F., Harrow, M., Whiteside, J.E., Risk for bipolar illness in patients initially hospitalized for unipolar depression. Am. J. Psychiatry 158:8 (2001), 1265–1270.
36. Goldstein, B.I., Kemp, D.E., Soczynska, J.K., McIntyre, R.S., Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: A systematic review of the literature. J. Clin. Psychiatry 70:8 (2009), 1078–1090, 10.4088/JCP.08r04505\r10.4088/JCP.08r04505.
37. Goodwin, F.K., Ghaemi, S.N., Understanding manic-depressive illness. Arch. Gen. Psychiatry 55:1 (1998), 23–25.
38. Goodwin, F.K., Ghaemi, S.N., Bipolar disorder. Dialogues Clin. Neurosci. 1:1 (1999), 41–51.
39. Gorwood, Philip, Corruble, Emmanuelle, Falissard, Bruno, Goodwin, Guy M., Toxic effects of depression on brain function: Impairment of delayed recall and the cumulative length of depressive disorder in a large sample of depressed outpatients. Am. J. Psychiatr. 165:6 (2008), 731–739, 10.1176/appi.ajp.2008.07040574.
40. Gutierrez, Maria Jose, Scott, Jan, Psychological treatment for bipolar disorders – a review of randomised controlled trials. Eur. Arch. Psychiatry Clin. Neurosci. 254:2 (2004), 92–98, 10.1007/s00406-004-0463-8.
41. Hawton, Keith, Sutton, Lesley, Haw, Camilla, Sinclair, Julia, Harriss, Louise, Suicide and attempted suicide in bipolar disorder: A systematic review of risk factors. J. Clin. Psychiatry 66:6 (2005), 693–704.
42. Huxley, N.A., Parikh, S.V., Baldessarini, R.J., Effectiveness of psychosocial treatments in bipolar disorder: State of the evidence. Harv. Rev. Psychiatry 8:3 (2000), 126–140.
43. Ifteni, Petru, Christoph, U., Correll, Jimmi Nielsen, Burtea, Victoria, Kane, John M., Manu, Peter, Rapid clozapine titration in treatment-refractory bipolar disorder. J. Affect. Disord. 166 (2014), 168–172, 10.1016/j.jad.2014.04.020 (September).
44. Kalivas, Peter W., Volkow, Nora D., The neural basis of addiction: A pathology of motivation and choice. Am. J. Psychiatr., 2005, 10.1176/appi.ajp.162.8.1403.
45. Kalmar, Jessica H., Wang, Fei, Spencer, Linda, Edmiston, Erin, Cheryl, M., Lacadie, Andrés Martin, Todd Constable, R., et al. Preliminary evidence for progressive prefrontal abnormalities in adolescents and young adults with bipolar disorder. J. Int. Neuropsychol. Soc. 15:3 (2009), 476–481, 10.1017/S1355617709090584.
46. Kapczinski, Flávio, Dias, Vasco Videira, Kauer-Sant'Anna, Marcia, Frey, Benicio Noronha, Grassi-Oliveira, Rodrigo, Colom, Francesc, Berk, Michael, Clinical implications of a staging model for bipolar disorders. Expert. Rev. Neurother. 9:7 (2009), 957–966, 10.1586/ern.09.31.
47. Kendler, K.S., Thornton, L.M., Gardner, C.O., Genetic risk, number of previous depressive episodes, and stressful life events in predicting onset of major depression. Am. J. Psychiatry 158:4 (2001), 582–586.
48. Kessing, Lars Vedel, Andersen, Per Kragh, Predictive effects of previous episodes on the risk of recurrence in depressive and bipolar disorders. Curr. Psychiatry Rep. 7:6 (2005), 413–420.
49. Kessing, L.V., Andersen, P.K., Mortensen, P.B., Predictors of recurrence in affective disorder. A case register study. J. Affect. Disord. 49:2 (1998), 101–108.
50. Kessing, L.V., Andersen, P.K., Mortensen, P.B., Bolwig, T.G., Recurrence in affective disorder. I. Case register study. Br. J. Psychiatry J. Ment. Sci. 172 (1998), 23–28.
51. Kessing, L.V., Andersen, P.K., Mortensen, P.B., Bolwig, T.G., Recurrence in affective disorder. I. Case register study. Br. J. Psychiatry 172 (1998), 23–28, 10.1192/bjp.172.1.23.
52. Kessing, Vedel, Lars, Gerster Hansen, Mette, Kragh Andersen, Per, Course of illness in depressive and bipolar disorders: Naturalistic study, 1994–1999. Br. J. Psychiatry 185 (2004), 372–377, 10.1192/bjp.185.5.372 (NOV.).
53. Kessing, Lars Vedel, Hellmund, Gunnar, Andersen, Per Kragh, Predictors of excellent response to lithium: Results from a nationwide register-based study. Int. Clin. Psychopharmacol. 26:6 (2011), 323–328, 10.1097/YIC.0b013e32834a5cd0.
54. Ketter Terence, A., Houston, John P., Adams, David H., Risser, Richard C., Meyers, Adam L., Williamson, Douglas J., Tohen, Mauricio, Differential efficacy of olanzapine and lithium in preventing manic or mixed recurrence in patients with bipolar I disorder based on number of previous manic or mixed episodes. J. Clin. Psychiatry 67:1 (2006), 95–101.
55. Kim, Sanghyeon, Zavitsanou, Katerina, Gurguis, George, Webster, Maree J., Neuropathology markers and pathways associated with molecular targets for antipsychotic drugs in postmortem brain tissues: Exploration of drug targets through the stanley neuropathology integrative database. Eur. Neuropsychopharmacol. 22:10 (2012), 683–694, 10.1016/j.euroneuro.2012.01.010.
56. Kimmel, S.E., Calabrese, J.R., Woyshville, M.J., Meltzer, H.Y., Clozapine in treatment-refractory mood disorders. J. Clin. Psychiatry 55:Suppl. B (1994), 91–93 (September).
57. Konarski, Jakub Z., Roger, S., McIntyre, Sidney H., Kennedy, Shahryar Rafi-Tari, Soczynska, Joanna K., Ketter, Terence A., Volumetric neuroimaging investigations in mood disorders: Bipolar disorder versus major depressive disorder. Bipolar Disord. 10:1 (2008), 1–37, 10.1111/j.1399-5618.2008.00435.x.
58. Lauder, Sue D., Berk, Michael, David, J., Castle, Seetal Dodd, Berk, Lesley, The role of psychotherapy in bipolar disorder. Med. J. Aust. 193:4 Suppl (2010), S31–S35.
59. Leverich, Gabriele S., Post, Robert M., Course of bipolar illness after history of childhood trauma. Lancet 367:9516 (2006), 1040–1042, 10.1016/S0140-6736(06)68450-X.
60. Leverich, Gabriele S., McElroy, Susan L., Suppes, Trisha, Keck, Paul E., Denicoff, Kirk D., Nolen, Willem A., Altshuler, Lori L., Early physical and sexual abuse associated with an adverse course of bipolar illness. Biol. Psychiatry 51:4 (2002), 288–297, 10.1016/S0006-3223(01)01239-2.
61. Li, Xian-Bin, Tang, Yi-Lang, Wang, Chuan-Yue, de Leon, Jose, Clozapine for treatment-resistant bipolar disorder: A systematic review. Bipolar Disord., 2014, 10.1111/bdi.12272 (October).
62. Lish, J.D., Dime-Meenan, S., Whybrow, P.C., Price, R.A., Hirschfeld, R.M., The National Depressive and Manic-Depressive Association (DMDA) survey of bipolar members. J. Affect. Disord. 31:4 (1994), 281–294.
63. Lisy, Megan E., Kelly, B., Jarvis, Melissa P., DelBello, Neil P., Mills, Wade A., Weber, David Fleck, Strakowski, Stephen M., Adler, Caleb M., Progressive neurostructural changes in adolescent and adult patients with bipolar disorder. Bipolar Disord. 13:4 (2011), 396–405, 10.1111/j.1399-5618.2011.00927.x.
64. Liu, Jie, Blond, Benjamin N., van Dyck, Laura I., Spencer, Linda, Wang, Fei, Blumberg, Hilary P., Trait and state corticostriatal dysfunction in bipolar disorder during emotional face processing. Bipolar Disord. 14:4 (2012), 432–441, 10.1111/j.1399-5618.2012.01018.x.
65. Lyoo, In Kyoon, Kyu Lee, Ho, Hyun Jung, Ji, Noam, Gil G., Renshaw, Perry F., White matter hyperintensities on magnetic resonance imaging of the brain in children with psychiatric disorders. Compr. Psychiatry 43 (2002), 361–368, 10.1053/comp.2002.34636.
66. Malhi, Gin S., Bargh, Danielle M., Kuiper, Sandy, Coulston, Carissa M., Das, Pritha, Modeling bipolar disorder suicidality. Bipolar Disord., 2013, 10.1111/bdi.12093.
67. Malhi, Gin S., Bargh, Danielle M., Coulston, Carissa M., Das, Pritha, Berk, Michael, Predicting bipolar disorder on the basis of phenomenology: Implications for prevention and early intervention. Bipolar Disord., 2014, 10.1111/bdi.12133.
68. Martínez-Arán, Anabel, Vieta, Eduard, Reinares, María, Colom, Francesc, Torrent, Carla, Sánchez-Moreno, Jose, Benabarre, Antonio, Goikolea, José Manuel, Comes, Mercè, Salamero, Manel, Cognitive function across manic or hypomanic, depressed, and euthymic states in bipolar disorder. Am. J. Psychiatry 161:2 (2004), 262–270.
69. Martínez-Arán, Anabel, Torrent, Carla, Brisa, Solé, Mar Bonnín, C., Adriane, R., Rosa, José Sánchez-Moreno, Vieta, Eduard, Functional remediation for bipolar disorder. Clin. Pract. Epidemiol. Mental Health 7:January (2011), 112–116, 10.2174/1745017901107010112.
70. Mathers, Colin D., Iburg, Kim M., Begg, Stephen, Adjusting for dependent comorbidity in the calculation of healthy life expectancy. Popul. Health Metrics, 4, 2006, 4, 10.1186/1478-7954-4-4 (January).
71. Maurer, Iris C., Schippel, Patricia, Volz, Hans-Peter, Lithium-induced enhancement of mitochondrial oxidative phosphorylation in human brain tissue. Bipolar Disord. 11:5 (2009), 515–522, 10.1111/j.1399-5618.2009.00729.x.
72. McIntyre, Roger S., Correll, Christoph, Predicting and preventing bipolar disorder: The need to fundamentally advance the strategic approach. Bipolar Disord. 16:5 (2014), 451–454, 10.1111/bdi.12216.
73. McNamara Robert, K., Nandagopal, Jayasree J., Strakowski, Stephen M., DelBello, Melissa P., Preventative strategies for early-onset bipolar disorder: Towards a clinical staging model. CNS Drugs 24:12 (2010), 983–996, 10.2165/11539700-000000000-00000.
74. Merikangas, Kathleen R., Hagop, S., Akiskal, Jules Angst, Paul, E., Greenberg, Robert M.A., Hirschfeld, Maria Petukhova, Kessler, Ronald C., Lifetime and 12-month prevalence of bipolar spectrum disorder in the national comorbidity survey replication. Arch. Gen. Psychiatry 64:5 (2007), 543–552, 10.1001/archpsyc.64.5.543.
75. Modabbernia, Amirhossein, Taslimi, Shervin, Brietzke, Elisa, Ashrafi, Mandana, Cytokine alterations in bipolar disorder: A meta-analysis of 30 studies. Biol. Psychiatry 74:1 (2013), 15–25, 10.1016/j.biopsych.2013.01.007.
76. Moore Gregory, J., Cortese, Bernadette M., Glitz, Debra A., Zajac-Benitez, Caroline, Quiroz, Jorge A., Uhde, Thomas W., Drevets, Wayne C., Manji, Husseini K., A longitudinal study of the effects of lithium treatment on prefrontal and subgenual prefrontal gray matter volume in treatment-responsive bipolar disorder patients. J. Clin. Psychiatry 70:5 (2009), 699–705, 10.4088/JCP.07m03745.
77. Moorhead, T., William, J., McKirdy, James, Jessika, E., Sussmann, D., Hall, Jeremy, Lawrie, Stephen M., Johnstone, Eve C., McIntosh, Andrew M., Progressive gray matter loss in patients with bipolar disorder. Biol. Psychiatry 62:8 (2007), 894–900, 10.1016/j.biopsych.2007.03.005.
78. Moreno-Romero, J.A., Grimalt, R., Hair loss in infancy. G. Ital. Dermatol. Venereol. 149:1 (2014), 55–78.
79. Müller-Oerlinghausen, Bruno, Berghöfer, Anne, Bauer, Michael, Bipolar disorder. Lancet 359:9302 (2002), 241–247, 10.1016/S0140-6736(02)07450-0.
80. Munkholm, Klaus, Braüner, Julie Vestergaard, Kessing, Lars Vedel, Vinberg, Maj, Cytokines in bipolar disorder vs. Healthy control subjects: A systematic review and meta-analysis. J. Psychiatr. Res. 47:9 (2013), 1119–1133, 10.1016/j.jpsychires.2013.05.018.
81. Munkholm, Klaus, Vinberg, Maj, Kessing, Lars Vedel, Cytokines in bipolar disorder: A systematic review and meta-analysis. J. Affect. Disord. 144:1–2 (2013), 16–27, 10.1016/j.jad.2012.06.010.
82. Nielsen, Jimmi, Kane, John M., Correll, Christoph U., Real-world effectiveness of clozapine in patients with bipolar disorder: Results from a 2-year mirror-image study. Bipolar Disord. 14:8 (2012), 863–869, 10.1111/bdi.12018.
83. Nordentoft, Merete, Mortensen, Preben Bo, Pedersen, Carsten Bøcker, Absolute risk of suicide after first hospital contact in mental disorder. Arch. Gen. Psychiatry 68:10 (2011), 1058–1064, 10.1001/archgenpsychiatry.2011.113.
84. Pandya, Chirayu D., Howell, Kristy R., Pillai, Anilkumar, Antioxidants as potential therapeutics for neuropsychiatric disorders. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 46 (2013), 214–223.
85. Piggott, M.A., Perry, E.K., Marshall, E.F., McKeith, I.G., Johnson, M., Melrose, H.L., Court, J.A., et al. Nigrostriatal dopaminergic activities in dementia with Lewy bodies in relation to neuroleptic sensitivity: Comparisons with Parkinson's disease. Biol. Psychiatry 44:8 (1998), 765–774.
86. Poon, Shi Hui, Sim, Kang, Sum, Min Yi, Kuswanto, Carissa Nadia, Baldessarini, Ross J., Evidence-based options for treatment-resistant adult bipolar disorder patients. Bipolar Disord. 14:6 (2012), 573–584, 10.1111/j.1399-5618.2012.01042.x.
87. Post, R.M., Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. Am. J. Psychiatry 149:8 (1992), 999–1010.
88. Post, Robert M., Kindling and sensitization as models for affective episode recurrence, cyclicity, and tolerance phenomena. Neurosci. Biobehav. Rev. 31:6 (2007), 858–873, 10.1016/j.neubiorev.2007.04.003.
89. Post, Robert M., Mechanisms of illness progression in the recurrent affective disorders. Neurotox. Res. 18:3–4 (2010), 256–271, 10.1007/s12640-010-9182-2.
90. Post, Robert M., Kalivas, Peter, Bipolar disorder and substance misuse: Pathological and therapeutic implications of their comorbidity and cross-sensitisation. Br. J. Psychiatry 202:3 (2013), 172–176, 10.1192/bjp.bp.112.116855.
91. Post, Robert M., Fleming, Jaclyn, Kapczinski, Flavio, Neurobiological correlates of illness progression in the recurrent affective disorders. J. Psychiatr. Res. 46:5 (2012), 561–573, 10.1016/j.jpsychires.2012.02.004.
92. Rizzo, Lucas Bortolotto, Gazzi Costa, Leonardo, Mansur, Rodrigo B., Swardfager, Walter, Iole Belangero, Síntia, Grassi-Oliveira, Rodrigo, McIntyre, Roger S., Bauer, Moisés E., Brietzke, Elisa, The theory of bipolar disorder as an illness of accelerated aging: Implications for clinical care and research. Neurosci. Biobehav. Rev. 42:May (2014), 157–169, 10.1016/j.neubiorev.2014.02.004.
93. Robinson, Lucy J., Nicol Ferrier, I., Evolution of cognitive impairment in bipolar disorder: A systematic review of cross-sectional evidence. Bipolar Disord. 8:2 (2006), 103–116, 10.1111/j.1399-5618.2006.00277.x.
94. Rosa, A.R., González-Ortega, I., González-Pinto, A., Echeburúa, E., Comes, M., Martínez-Àran, A., Ugarte, A., Fernández, M., Vieta, E., One-year psychosocial functioning in patients in the early vs. Late stage of bipolar disorder. Acta Psychiatr. Scand. 125:4 (2012), 335–341, 10.1111/j.1600-0447.2011.01830.x.
95. Rosa, Adriane R., Pedro, V.S., Magalhães, Letícia Czepielewski, Sulzbach, Miréia Viana, Pedro, D., Goi, Eduard Vieta, Gama, Clarissa S., Kapczinski, Flávio, Clinical staging in bipolar disorder: Focus on cognition and functioning. J. Clin. Psychiatry 75:5 (2014), e450–e456, 10.4088/JCP.13m08625.
96. Rosenberg, Paul B., Michelle, M., Mielke, Qian-Li Xue, Carlson, Michelle C., Depressive symptoms predict incident cognitive impairment in cognitive healthy older women. Am. J. Geriatr. Psychiatry 18:3 (2010), 204–211, 10.1097/JGP.0b013e3181c53487.
97. Saczynski, J.S., Beiser, A., Seshadri, S., Auerbach, S., Wolf, P.A., Au, R., Depressive symptoms and risk of dementia: The Framingham Heart Study. Neurology 75:1 (2010), 35–41, 10.1212/WNL.0b013e3181e62138.
98. Sanches, Marsal, Roxsann, L., Roberts, Roberto B., Sassi, David Axelson, Nicoletti, Mark, Brambilla, Paolo, Hatch, John P., Developmental abnormalities in striatum in young bipolar patients: A preliminary study. Bipolar Disord. 7:2 (2005), 153–158, 10.1111/j.1399-5618.2004.00178.x.
99. Sant'Anna, Kauer, Flávio Kapczinski, Marcia, Andreazza, Ana C., Bond, David J., Lam, Raymond W., Trevor Young, L., Yatham, Lakshmi N., Brain-derived Neurotrophic factor and inflammatory markers in patients with early- vs. Late-stage bipolar disorder. Int. J. Neuropsychopharmacol. 12:4 (2009), 447–458, 10.1017/S1461145708009310.
100. Schneider, Marguerite Reid, DelBello, Melissa P., McNamara, Robert K., Strakowski, Stephen M., Adle, Caleb M., Neuroprogression in bipolar disorder. Bipolar Disord. 14:4 (2012), 356–374, 10.1111/j.1399-5618.2012.01024.x.
101. Schroeter, Matthias L., Steiner, Johann, Mueller, Karsten, Glial pathology is modified by Age in mood disorders – a systematic meta-analysis of serum S100B in vivo studies. J. Affect. Disord., 2011, 10.1016/j.jad.2010.11.008.
102. Scott, Jan, Gutierrez, Maria Jose, The current status of psychological treatments in bipolar disorders: A systematic review of relapse prevention. Bipolar Disord. 6:6 (2004), 498–503, 10.1111/j.1399-5618.2004.00153.x.
103. Scott, Jan, Paykel, Eugene, Morriss, Richard, Bentall, Richard, Kinderman, Peter, Johnson, Tony, Abbott, Rosemary, Hayhurst, Hazel, Cognitive-behavioural therapy for severe and recurrent bipolar disorders: Randomised controlled trial. Br. J. Psychiatry J. Ment. Sci. 188:April (2006), 313–320, 10.1192/bjp.188.4.313.
104. Shao, Li, Trevor Young, L., Wang, Jun-Feng, Chronic treatment with mood stabilizers lithium and valproate prevents excitotoxicity by inhibiting oxidative stress in Rat cerebral cortical cells. Biol. Psychiatry 58:11 (2005), 879–884, 10.1016/j.biopsych.2005.04.052.
105. Shao, Li, Sun, Xiujun, Xu, Li, Trevor Young, L., Wang, Jun Feng, Mood stabilizing drug lithium increases expression of endoplasmic reticulum stress proteins in primary cultured Rat cerebral cortical cells. Life Sci. 78:12 (2006), 1317–1323, 10.1016/j.lfs.2005.07.007.
106. Smith, R.S., The macrophage theory of depression. Med. Hypotheses 35:4 (1991), 298–306, 10.1016/0306-9877(91)90272-Z.
107. Smith, R.S., A comprehensive macrophage-T-lymphocyte theory of schizophrenia. Med. Hypotheses, 1992, 10.1016/0306-9877(92)90117-U.
108. Soeiro-de-Souza, Márcio Gerhardt, Ana, C., Andreazza, Andre F., Carvalho, Rodrigo Machado-Vieira, Trevor Young, L., Moreno, Ricardo Alberto, Number of manic episodes is associated with elevated DNA oxidation in bipolar I disorder. Int. J. Neuropsychopharmacol. 16 (2013), 1505–1512, 10.1017/S1461145713000047.
109. Sousa, De, Rafael, T., Zarate, Carlos A., Zanetti, Marcus V., Costa, Alana C., Talib, Leda L., Gattaz, Wagner F., Machado-Vieira, Rodrigo, Oxidative stress in early stage bipolar disorder and the association with response to lithium. J. Psychiatr. Res. 50:1 (2014), 36–41, 10.1016/j.jpsychires.2013.11.011.
110. Sprooten, Emma, Fleming, Kathryn M., Thomson, Pippa A., Bastin, Mark E., Whalley, Heather C., Hall, Jeremy, Sussmann, Jess E., White matter integrity as an intermediate phenotype: Exploratory genome-wide association analysis in individuals at high risk of bipolar disorder. Psychiatry Res., 2012, 10.1016/j.psychres.2012.11.002.
111. Strakowski, S.M., DelBello, M.P., Sax, K.W., Zimmerman, M.E., Shear, P.K., Hawkins, J.M., Larson, E.R., Brain magnetic resonance imaging of structural abnormalities in bipolar disorder. Arch. Gen. Psychiatry 56:3 (1999), 254–260.
112. Strakowski, Stephen M., Melissa, P., DelBello, Molly E., Zimmerman, Glen E., Getz, Neil P., Mills, Jennifer Ret, Shear, Paula, Adler, Caleb M., Ventricular and periventricular structural volumes in first- versus multiple-episode bipolar disorder. Am. J. Psychiatry 159:11 (2002), 1841–1847.
113. Strakowski, Stephen M., Caleb, M., Adler, Scott K., Holland, Neil Mills, DelBello, Melissa P., A preliminary FMRI study of sustained attention in euthymic. Unmedicated Bipolar Disord. Neuropsychopharmacol., 29, 2004, 10.1038/sj.npp.1300492.
114. Strakowski, Stephen M., Eliassen, James C., Lamy, Martine, Cerullo, Michael A., Allendorfer, Jane B., Madore, Michelle, Lee, Jing Huei, et al. Functional magnetic resonance imaging brain activation in bipolar mania: Evidence for disruption of the ventrolateral prefrontal-amygdala emotional pathway. Biol. Psychiatry 69:4 (2011), 381–388, 10.1016/j.biopsych.2010.09.019.
115. Strakowski, Stephen M., Adler, Caleb M., Almeida, Jorge, Altshuler, Lori L., Blumberg, Hilary P., Chang, Kiki D., Delbello, Melissa P., The functional neuroanatomy of bipolar disorder: A consensus model. Bipolar Disord., 2012, 10.1111/j.1399-5618.2012.01022.x.
116. Swann, A.C., Bowden, C.L., Calabrese, J.R., Dilsaver, S.C., Morris, D.D., Differential effect of number of previous episodes of affective disorder on response to lithium or divalproex in acute mania. Am. J. Psychiatry 156:8 (1999), 1264–1266.
117. Torrent, Carla, del Mar, Caterina, Bonnin, Anabel Martínez-Arán, Valle, Jesús, Benedikt, L., Amann, Ana González-Pinto, Crespo, José Manuel, et al. Efficacy of functional remediation in bipolar disorder: A multicenter randomized controlled study. Am. J. Psychiatry 170:8 (2013), 852–859, 10.1176/appi.ajp.2012.12070971.
118. Torres, I.J., Boudreau, V.G., Yatham, L.N., Neuropsychological functioning in euthymic bipolar disorder: A meta-analysis. Acta Psychiatr. Scand. Suppl. 434 (2007), 17–26, 10.1111/j.1600-0447.2007.01055.x (January).
119. Townsend, Jennifer, Altshuler, Lori L., Emotion processing and regulation in bipolar disorder: A review. Bipolar Disord., 2012, 10.1111/j.1399-5618.2012.01021.x.
120. Townsend, Jennifer D., Bookheimer, Susan Y., Foland-Ross, Lara C., Moody, Teena D., Eisenberger, Naomi I., Fischer, Jeffrey S., Cohen, Mark S., Sugar, Catherine A., Altshuler, Lori L., Deficits in inferior frontal cortex activation in euthymic bipolar disorder patients during a response inhibition task. Bipolar Disord. 14:4 (2012), 442–450, 10.1111/j.1399-5618.2012.01020.x.
121. Vernon, Anthony C., Natesan, Sridhar, William, R., Crum, Jonathan D., Cooper, Michel Modo, Williams, Steven C.R., Kapur, Shitij, Contrasting effects of haloperidol and lithium on rodent brain structure: A magnetic resonance imaging study with postmortem confirmation. Biol. Psychiatry 71:10 (2012), 855–863, 10.1016/j.biopsych.2011.12.004.
122. Versace, Amelia, Ladouceur, Cecile D., Romero, Soledad, Birmaher, Boris, Axelson, David A., Kupfer, David J., Phillips, Mary L., Altered development of white matter in youth at high familial risk for bipolar disorder: A diffusion tensor imaging study. J. Am. Acad. Child Adolesc. Psychiatry, 49(12), 2010, 10.1016/j.jaac.2010.09.007.
123. Wang, J.F., Azzam, J.E., Young, L.T., Valproate inhibits oxidative damage to lipid and protein in primary cultured Rat cerebrocortical cells. Neuroscience 116:2 (2003), 485–489, 10.1016/S0306-4522(02)00655-3.
124. Wang, Jun-Feng, Shao, Li, Sun, Xiujun, Trevor Young, L., Increased oxidative stress in the anterior cingulate cortex of subjects with bipolar disorder and schizophrenia. Bipolar Disord. 11:5 (2009), 523–529, 10.1111/j.1399-5618.2009.00717.x.